VSV < Vaccination < Vaccination (adverse effects)

Facettes : Author.f AffPays.f AffRegion.f AffVille.f AffOrg.f KwdFr.f Mesh.f MeshFr.f Teeft.f

List of bibliographic references indexed by Vaccination

Number of relevant bibliographic references: 44.
[0-20] [0 - 20][0 - 44][20-40]

Ident.	Authors (with country if any)	Title
000125 (2018-04)	Tomi Sarkanen ; Anniina P. E. Alakuijala ; Yves Dauvilliers [France] ; Markku Partinen	Incidence of narcolepsy after H1N1 influenza and vaccinations: Systematic review and meta-analysis
000128 (2018-03)	V. Busignies [France] ; G. Simon [France] ; G. Mollereau [France] ; O. Bourry [France] ; V. Mazel [France] ; Manuel Rosa-Calatrava [France] ; P. Tchoreloff [France]	Development and pre-clinical evaluation in the swine model of a mucosal vaccine tablet for human influenza viruses: A proof-of-concept study
000160 (2018)	Daniil A. Korenkov [Russie] ; Karen L. Laurie [Australie] ; Patrick C. Reading [Australie] ; Louise A. Carolan [Australie] ; Kok Fei Chan [Australie] ; Irina I. Isakova-Sivak [Russie] ; Tatiana A. Smolonogina [Russie] ; Kanta Subbarao [Australie] ; Ian G. Barr [Australie] ; Julie Villanueva [États-Unis] ; Svetlana Shcherbik [États-Unis] ; Tatiana Bousse [États-Unis] ; Larisa G. Rudenko [Russie]	Safety, immunogenicity and protection of A(H3N2) live attenuated influenza vaccines containing wild-type nucleoprotein in a ferret model.
000220 (2018)	Guo Luo ; Aditya Ambati ; Ling Lin ; Mélodie Bonvalet ; Markku Partinen [Finlande] ; Xuhuai Ji ; Holden Terry Maecker ; Emmanuel Jean-Marie Mignot	Autoimmunity to hypocretin and molecular mimicry to flu in type 1 narcolepsy
000377 (2016-07)	Stéphanie Fougerolle [France] ; Loïc Legrand [France] ; Dion Garrett [Royaume-Uni] ; Ilhan Birand [Royaume-Uni] ; Marc Foursin [France] ; Xavier D Blon [France] ; Pierre Bayssat [France] ; Richard Newton [Royaume-Uni] ; Stéphane Pronost [France] ; Romain Paillot [Royaume-Uni]	Influential factors inducing suboptimal humoral response to vector-based influenza immunisation in Thoroughbred foals
000389 (2016)	Paul Loubet [France] ; Nezha Samih-Lenzi [France] ; Florence Galtier [France] ; Philippe Vanhems [France] ; Pierre Loulergue [France] ; Xavier Duval [France] ; Stéphane Jouneau [France] ; Déborah Postil [France] ; Sylvie Rogez [France] ; Martine Valette [France] ; Corinne Merle [France] ; Corinne Régis [France] ; Yolande Costa [France] ; Zineb Lesieur [France] ; Pierre Tattevin [France] ; Bruno Lina [France] ; Fabrice Carrat [France] ; Odile Launay [France]	Factors associated with poor outcomes among adults hospitalised for influenza in France: A three-year prospective multicenter study
000963 (2013)	M. Panning [Allemagne]	Influenza heute und in Zukunft
000A85 (2012)	Kawsar R. Talaat ; Ruth A. Karron ; Philana H. Liang ; Bridget A. Mcmahon ; Catherine J. Luke ; Bhagvanji Thumar ; Grace L. Chen ; Ji-Young Min ; Elaine W. Lamirande ; Hong Jin ; Kathy L. Coelingh ; George W. Kemble ; Kanta Subbarao	An open‐label phase I trial of a live attenuated H2N2 influenza virus vaccine in healthy adults
000B97 (2011)	Guus F. Rimmelzwaan [Pays-Bas] ; Rogier Bodewes ; Albert D M E. Osterhaus	Vaccination strategies to protect children against seasonal and pandemic influenza.
000D93 (2010)	N A Mazurkova ; N N Ryndiuk ; L N Shishkina ; V A Ternovo ; Iu V. Tumanov ; L E Bulychev ; M O Skarnovich ; A S Kabanov ; S G Panchenko ; R P Ale Nikov ; T N Il'Ina ; V I Kuzubov ; S Ia Mel'Nikov ; A N Mironov ; S A Korovkin ; A N Sergeev ; I G Drozdov	[Results of clinical trials on reactogenicity, safety, and immunogenicity of influenza allantoic intranasal live vaccine "Ultragrivac" (type A/H5N2)].
000E67 (2010)	Chih-Jen Wei [États-Unis] ; Jeffrey C. Boyington ; Patrick M. Mctamney ; Wing-Pui Kong ; Melissa B. Pearce ; Ling Xu ; Hanne Andersen ; Srinivas Rao ; Terrence M. Tumpey ; Zhi-Yong Yang ; Gary J. Nabel	Induction of broadly neutralizing H1N1 influenza antibodies by vaccination.
001087 (2009)	Shufang Fan [République populaire de Chine] ; Yuwei Gao ; Kyoko Shinya ; Chris Kafai Li ; Yanbing Li ; Jianzhong Shi ; Yongping Jiang ; Yongbing Suo ; Tiegang Tong ; Gongxun Zhong ; Jiasheng Song ; Ying Zhang ; Guobin Tian ; Yuntao Guan ; Xiao-Ning Xu ; Zhigao Bu ; Yoshihiro Kawaoka [États-Unis] ; Hualan Chen	Immunogenicity and protective efficacy of a live attenuated H5N1 vaccine in nonhuman primates.
001243 (2008)	R J Green [Afrique du Sud] ; C. Feldman ; B. Schoub ; G A Richards ; S A Madhi ; H J Zar ; U. Lalloo ; K. Klugman ; D. Phillips ; N A Cameron ; R R Eggers	Influenza guideline for South Africa--update 2008.
001653 (2004)	Thomas Palker [États-Unis] ; Irina Kiseleva ; Kimberly Johnston ; Qin Su ; Timothy Toner ; Christopher Szymkowiak ; Wan-Sang Kwan ; Boris Rubin ; Luba Petrukhin ; Joan Wlochowski ; Juanita Monteiro ; Nikolai Kraiouchkine ; Daniel Distefano ; Larisa Rudenko ; Alan Shaw ; Rima Youil	Protective efficacy of intranasal cold-adapted influenza A/New Caledonia/20/99 (H1N1) vaccines comprised of egg- or cell culture-derived reassortants.
001795 (2002)	Yu. A. Desheva ; G. V. Danini ; E. P. Grigoryeva ; S. A. Donina ; I. V. Kiseleva ; A. R. Rekstin ; L. A. Ermakova ; V. K. Natsina ; V. M. Nikolaeva ; N. I. Lonskaya ; G. A. Elshina ; V. G. Zhavoronkov ; V. P. Drinevsky ; M. K. Erofeeva ; A. N. Naikhin ; L. G. Rudenko	En Russe
001872 (2001)	M. D. Wareing [Australie] ; J. M. Watson [Australie] ; M. J. Brooks [Australie] ; G. A. Tannock [Australie]	Immunogenic and isotype‐specific responses to russian and US cold‐adapted influenza a vaccine donor strains A/Leningrad/134/17/57, A/Leningrad/134/47/57, and A/Ann Arbor/6/60 (H2N2) in mice
001B22 (1997)	K. Hashigucci ; S. Tamura ; T. Kurata ; H. Kamiya ; T. Ishidate	[Efficacy of nasal influenza vaccine combined with Escherichia coli heat-labile enterotoxin B subunit containing a trace amount of the holotoxin in healthy volunteers].
001D27 (1995)	M. Aymard [France] ; M. F. Odelin [France] ; J. Million-Jolly [France]	Immunité antigrippale
001D60 (1995)	Marco Salvetti [Italie] ; Angela Pisani [Italie] ; Stefano Bastianello [Italie] ; Enrico Millefiorini [Italie] ; Carla Buttinelli [Italie] ; Carlo Pozzilli [Italie]	Clinical and MRI assessment of disease activity in patients with multiple sclerosis after influenza vaccination
001E68 (1993)	Louis F. Fries [États-Unis] ; Susan B. Dillon [États-Unis] ; James E. K. Hildreth [États-Unis] ; Ruth A. Karron [États-Unis] ; Ann W. Funkhouser [États-Unis] ; Carl J. Friedman [États-Unis] ; Christopher S. Jones [États-Unis] ; Vasantha G. Culleton [États-Unis] ; Mary Lou Clements [États-Unis]	Safety and Immunogenicity of a Recombinant Protein Influenza A Vaccine in Adult Human Volunteers and Protective Efficacy against Wild-Type H1N1 Virus Challenge
002128 (1990)	I. N. Mbawuike ; H. R. Six ; T. R. Cate ; R. B. Couch	Vaccination with inactivated influenza A virus during pregnancy protects neonatal mice against lethal challenge by influenza A viruses representing three subtypes

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/H2N2V1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i -k "Vaccination" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i  \
                -Sk "Vaccination" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    H2N2V1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Vaccination
}}

---

This area was generated with Dilib version V0.6.33. Data generation: Tue Apr 14 19:59:40 2020. Site generation: Thu Mar 25 15:38:26 2021